Form 4: Director Devdatt Kurdikar Increases ZBH Holdings

Director Devdatt Kurdikar acquired 154.356 phantom stock units under the Zimmer Biomet deferred compensation plan.

Summary

• Director Devdatt Kurdikar acquired 154.356 phantom stock units on March 31, 2026.
• The acquisition was made under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The units are valued at a 1-for-1 conversion ratio to common stock.
• Following this transaction, the director holds a total of 1,928.847 phantom stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.

Positives

• Demonstrates continued alignment of director interests with long-term shareholder value through deferred compensation participation.

Negatives

• None identified.

Risks

• Value of phantom stock units is tied to the future performance of Zimmer Biomet common stock.

Future Outlook

The units are scheduled to be settled in shares of company common stock within sixty days after the cessation of the reporting person's service as a Director.

Management Comments

• The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director compensation and equity alignment, common among large-cap medical device companies to ensure board members maintain a vested interest in company performance.

Comparison to Industry Standards

• The use of deferred compensation plans for non-employee directors is a standard corporate governance practice among S&P 500 companies like Stryker, Medtronic, and Boston Scientific.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Settlement of phantom stock units into common stock upon the director's eventual departure from the board.

Key Dates

Keywords

Zimmer Biomet, ZBH, Form 4, Insider Trading, Director Compensation, Phantom Stock